跳至主要内容
临床试验/NCT02509650
NCT02509650Unknown不适用

Identification of Mutations Responsible for Rare Familial Skin Diseases by Next Generation Sequencing

University Hospital, Strasbourg, France2 个研究点 分布在 1 个国家目标入组 25 人开始时间: 2015年9月最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
25
试验地点
2
主要终点
Number of patients with a deleterious mutation

研究概览

简要总结

The primary purpose of the protocol is to use next generation sequencing to identify pathogenic variants in genes involved in very rare skin diseases.

The secondary purpose will be to study the genotype-phenotype correlation in order to re-evaluate the classification of these disorders. This work could help in the understanding of the physiopathology of very rare skin disorders.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
2 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients affected by familial lipomatosis
  • patients with rare dermatologic disease without molecular diagnosis
  • written informed consent is obtained from the patient and his/her family

排除标准

  • the patient does not want to participate to the protocol
  • the patient is already included in another study using next generation sequencing technologies

结局指标

主要结局

Number of patients with a deleterious mutation

时间窗: 6 months

Validation of the exome sequencing results will be done by sanger sequencing

次要结局

未报告次要终点

研究者

发起方
University Hospital, Strasbourg, France
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验